Curbstone Financial Management Corp reports 2.01% increase in ownership of BRM / Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

DE ˙ XTRA ˙ US1101221083

47,43 € ↓ -0,01 (-0,01%)

2026-06-04
DEL PRIS

Security	DE:BRM / Bristol-Myers Squibb Company
Institution	Curbstone Financial Management Corp
Latest Disclosed Ownership	17,744 shares
Latest Disclosed Value	$ 1,076,174

On April 15, 2026 - Curbstone Financial Management Corp filed a 13F-HR form disclosing ownership of 17,744 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $930,140 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 23, 2026 disclosing 17,394 shares of Bristol-Myers Squibb Company. This represents a change in shares of 2.01% during the quarter. The current value of the position is $841,598 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-04-15	2026-03-31	13F	Bristol Myers	COM	110122108	17,744	350	2.01	1,076	14.71	0.2059
2026-01-23	2025-12-31	13F	Bristol Myers	COM	110122108	17,394	-2,100	-10.77	938	6.71	0.1795
2025-10-15	2025-09-30	13F	Bristol Myers	COM	110122108	19,494	560	2.96	879	0.34	0.1690
2025-07-29	2025-06-30	13F	Bristol Myers	COM	110122108	18,934	-3,012	-13.72	876	-34.53	0.1798
2025-04-15	2025-03-31	13F	Bristol Myers	COM	110122108	21,946	2,612	13.51	1,339	22.42	0.2821
2025-01-22	2024-12-31	13F	Bristol-Myers Squibb	COM	110122108	19,334	-130	-0.67	1,094	8.54	0.2316
2024-10-03	2024-09-30	13F	Bristol-Myers Squibb	COM	110122108	19,464	-326	-1.65	1,007	22.66	0.2154
2024-07-03	2024-06-30	13F	Bristol-Myers Squibb	COM	110122108	19,790	-1,570	-7.35	822	-29.10	0.1785
2024-04-09	2024-03-31	13F	Bristol-Myers Squibb	COM	110122108	21,360	260	1.23	1,158	7.02	0.2503
2024-01-08	2023-12-31	13F	Bristol-Myers Squibb	COM	110122108	21,100	-36	-0.17	1,083	-11.75	0.2457
2023-10-10	2023-09-30	13F	Bristol-Myers Squibb	COM	110122108	21,136	0	0.00	1,227	-9.25	0.3034
2023-07-05	2023-06-30	13F	Bristol-Myers Squibb	COM	110122108	21,136	0	0.00	1,352	-7.72	0.3222
2023-05-12	2023-03-31	13F	Bristol-Myers Squibb	COM	110122108	21,136	50	0.24	1,465	146,300.00	0.3565
2023-01-19	2022-12-31	13F	Bristol-Myers Squibb	COM	110122108	21,086	-2,122	-9.14	2	-99.94	0.3795
2022-10-05	2022-09-30	13F	Bristol-Myers Squibb	COM	110122108	23,208	1,700	7.90	1,650	-0.36	0.4103
2022-08-04	2022-06-30	13F	Bristol-Myers Squibb	COM	110122108	21,508	-176	-0.81	1,656	4.55	0.3852
2022-04-18	2022-03-31	13F	Bristol-Myers Squibb	COM	110122108	21,684	200	0.93	1,584	18.21	0.2922
2022-01-19	2021-12-31	13F	Bristol-Myers Squibb	COM	110122108	21,484	1,800	9.14	1,340	15.02	0.2369
2021-10-06	2021-09-30	13F	Bristol-Myers Squibb	COM	110122108	19,684	-244	-1.22	1,165	-12.54	0.2197
2021-07-09	2021-06-30	13F	Bristol-Myers Squibb	COM	110122108	19,928	-100	-0.50	1,332	5.38	0.2503
2021-04-05	2021-03-31	13F	Bristol-Myers Squibb	COM	110122108	20,028	-110	-0.55	1,264	1.20	0.2522
2021-01-14	2020-12-31	13F	Bristol-Myers Squibb	COM	110122108	20,138	-600	-2.89	1,249	-0.08	0.2607
2020-10-02	2020-09-30	13F	Bristol-Myers Squibb	COM	110122108	20,738	536	2.65	1,250	5.22	0.2989
2020-07-10	2020-06-30	13F	Bristol-Myers Squibb	COM	110122108	20,202	0	0.00	1,188	5.51	0.3076
2020-04-20	2020-03-31	13F	Bristol-Myers Squibb	COM	110122108	20,202	-492	-2.38	1,126	-15.21	0.3401
2020-01-10	2019-12-31	13F	Bristol-Myers Squibb	COM	110122108	20,694	1,110	5.67	1,328	33.74	0.3162
2019-10-18	2019-09-30	13F	Bristol-Myers Squibb	COM	110122108	19,584	500	2.62	993	14.80	0.2550
2019-07-09	2019-06-30	13F	Bristol-Myers Squibb	COM	110122108	19,084	4,692	32.60	865	25.91	0.2273
2019-04-10	2019-03-31	13F	Bristol-Myers Squibb	COM	110122108	14,392	1,850	14.75	687	5.37	0.1870
2019-01-09	2018-12-31	13F/A-1	Bristol-Myers Squibb	COM	110122108	12,542	550	4.59	652	-12.37	0.1951
2019-01-08	2018-12-31	13F	Bristol-Myers Squibb	COM	110122108	11,814	-178		654
2018-10-10	2018-09-30	13F	Bristol-Myers Squibb	COM	110122108	11,992	178	1.51	744	13.76	0.1944
2018-07-06	2018-06-30	13F	Bristol-Myers Squibb	COM	110122108	11,814	0	0.00	654	-12.45	0.1807
2018-04-10	2018-03-31	13F	Bristol-Myers Squibb	COM	110122108	11,814	5,907	100.00	747	106.35	0.2113
2018-01-08	2017-12-31	13F	Bristol-Myers Squibb	COM	110122108	5,907	-6,907	-53.90	362	-55.69	0.1999
2017-10-03	2017-09-30	13F	Bristol-Myers Squibb	COM	110122108	12,814	6,510	103.27	817	132.76	0.2366
2017-07-07	2017-06-30	13F	Bristol-Myers Squibb	COM	110122108	6,304	0	0.00	351	2.33	0.2109
2017-04-05	2017-03-31	13F	Bristol-Myers Squibb	COM	110122108	6,304	-140	-2.17	343	-9.02	0.2103
2017-01-10	2016-12-31	13F	Bristol-Myers Squibb	COM	110122108	6,444	-6,444	-50.00	377	-45.76	0.2376
2016-10-05	2016-09-30	13F	Bristol-Myers Squibb	COM	110122108	12,888	84	0.66	695	-26.22	0.2229
2016-07-07	2016-06-30	13F	Bristol-Myers Squibb	COM	110122108	12,804	-300	-2.29	942	12.54	0.3155
2016-04-05	2016-03-31	13F	Bristol-Myers Squibb	COM	110122108	13,104	-200	-1.50	837	-8.52	0.2812
2016-01-07	2015-12-31	13F	Bristol-Myers Squibb	COM	110122108	13,304	5,927	80.34	915	109.38	0.3129
2015-10-06	2015-09-30	13F	Bristol-Myers Squibb	COM	110122108	7,377	-400	-5.14	437	-15.47	0.3168
2015-07-14	2015-06-30	13F	Bristol-Myers Squibb	COM	110122108	7,777	-1,150	-12.88	517	-10.24	0.3438
2015-04-16	2015-03-31	13F	Bristol-Myers Squibb	COM	110122108	8,927	-150	-1.65	576	7.46	0.3880
2015-01-23	2014-12-31	13F	Bristol-Myers Squibb	COM	110122108	9,077	125	1.40	536	17.03	0.4126
2014-10-21	2014-09-30	13F	Bristol-Myers Squibb	COM	110122108	8,952	0	0.00	458	5.53	0.3607
2014-07-25	2014-06-30	13F	Bristol-Myers Squibb	COM	110122108	8,952	0	0.00	434	-6.67	0.3324
2014-05-15	2014-03-31	13F	Bristol-Myers Squibb	COM	110122108	8,952	8,952		465		0.3796

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.